Elsevier

International Journal of Cardiology

Volume 249, 15 December 2017, Pages 169-170
International Journal of Cardiology

Editorial
Liver dysfunction and congenital heart disease: Are we ready for the epidemic?

https://doi.org/10.1016/j.ijcard.2017.08.050Get rights and content

Section snippets

Conflict of interest

The author report no relationships that could be construed as a conflict of interest.

References (7)

There are more references available in the full text version of this article.

Cited by (7)

  • Heart Transplant Indications, Considerations, and Outcomes in Fontan Patients: Age-Related Nuances, Transplant Listing, and Disease-Specific Indications

    2022, Canadian Journal of Cardiology
    Citation Excerpt :

    These are then applied on a patient-by-patient basis, factoring in the totality of hepatic and other risk factors in each case. This approach will remain the most appropriate until more conclusive data exist regarding the effect of FALD on perioperative HTx risk and long-term post-transplant survival, as well as the predictive value of the various hepatic health indices.54 Intraoperative and postoperative bleeding have a critical impact on peri-transplant mortality.

  • Anesthetic Considerations for Fontan-Associated Liver Disease and the Failing Fontan Circuit

    2020, Journal of Cardiothoracic and Vascular Anesthesia
    Citation Excerpt :

    It is estimated that the incidence of liver dysfunction in all adult patients undergoing elective surgery is 1 in 700 and as many as 10% of patients with advanced liver disease will require surgery in the last 2 years of life.58 In adult patients with CHD and especially those with SV physiology, liver dysfunction is very common.59 In FALD, it is important for the anesthesiologist to understand the complex pathophysiological interactions of the cardiovascular and hepatic systems and the effects of anesthesia.60

View all citing articles on Scopus
View full text